BioStock: Immunicum’s immuno-oncology platform shares the spotlight at Cancer Progress conference
The field of immuno-oncology encompasses several strategies to push our own immune system to be more sensitive and reactive to cancer cells and metastases. Swedish biotech Immunicum have developed their own strategy and were asked to present and discuss it on a panel of immuno-oncology experts at the 31st Annual Cancer Progress Conference last week. BioStock caught up with Immunicum’s COO, Sijme Zeilemaker, who represented the company on that panel, to learn more about the discussion and how Immunicum is making a difference in the field.
Read the full interview with Sijme Zeilemaker at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se